Skip to contentK
Kewaunee Scientific Corp
K
KEQUKewaunee Scientific Corp Q3 2026 · 10-Q
Revenue$69.40M$69.40M+3.3% vs Q3 2025 Net Income$692.00K$692.00K−48.9% vs Q3 2025 EPS Diluted$0.23$0.23−48.9% vs Q3 2025 Gross Profit$18,545,000+0.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kewaunee Scientific Corp · CIK 55529 · Engraved from SEC EDGAR
Operating Cash Flowderived$11,647,000N/M Free Cash Flowderived$10,979,000N/M Margins · derivedGross margin26.7%−0.6 pt vs Q3 2025
Operating margin3.7%+0.4 pt vs Q3 2025
Net margin1.0%−1.0 pt vs Q3 2025
ended Jan 31, 2026 · filed Mar 13, 2026 · 41 d after period end